Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cao, 2020, Coronavirus disease 2019: a new severe acute respiratory syndrome from Wuhan in China, Acta Virol, 64, 245, 10.4149/av_2020_201
Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, 20, 533, 10.1016/S1473-3099(20)30120-1
Lwin, 2020, Global sentiments surrounding the COVID-19 Pandemic on Twitter: analysis of Twitter trends, JMIR Public Health Surveill, 6, e19447, 10.2196/19447
Bajaj, 2020, Understanding SARS-CoV-2: genetic diversity, transmission and cure in human, Indian J Microbiol, 1
Morawska, 2020, It is time to address airborne transmission of COVID-19, Clin Infect Dis
Liu, 2020, Large SARS-CoV-2 outbreak caused by asymptomatic traveler, China. Emerg Infect Dis., 29
Lavezzo, 2020, Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo', Nature, 584, 425, 10.1038/s41586-020-2488-1
Baig, 2020, Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19), J Med Virol, 3
He, 2020, Temporal dynamics in viral shedding and transmissibility of COVID-19, Nat Med, 26, 672, 10.1038/s41591-020-0869-5
Liu, 2020, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis, 20, 656, 10.1016/S1473-3099(20)30232-2
Azkur, 2020, Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19, Allergy, 75, 1564, 10.1111/all.14364
Sokolowska, 2020, Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the European Academy of Allergy and Clinical Immunology (EAACI), Allergy, 10.1111/all.14462
Han, 2020, Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors, Emerg Microbes Infect, 9, 1123, 10.1080/22221751.2020.1770129
Catanzaro, 2020, Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2, Signal Transduct Target Ther, 5, 84, 10.1038/s41392-020-0191-1
Cipriano, 2020, Gastrointestinal infection could be new focus for coronavirus diagnosis, Cureus, 12, e7422
Chakraborty, 2020, The COVID-19 pandemic: catching up with the cataclysm, F1000 Faculty, 9
Parasa, 2020, Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with Coronavirus disease 2019: a systematic review and meta-analysis, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.11335
Kopel, 2020, Clinical insights into the gastrointestinal manifestations of COVID-19, Dig Dis Sci, 65, 1932, 10.1007/s10620-020-06362-8
Xiong, 2020, The role of human coronavirus infection in pediatric acute gastroenteritis, Pediatr Infect Dis J, 39, 645, 10.1097/INF.0000000000002752
Li, 2020, Atypical presentation of SARS-CoV-2 infection: a case report, World J Clin Cases, 8, 1265, 10.12998/wjcc.v8.i7.1265
Lin, 2020, Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection, Gut, 69, 997, 10.1136/gutjnl-2020-321013
Jin, 2020, Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms, Gut, 69, 1002, 10.1136/gutjnl-2020-320926
Leung, 2003, Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection, Gastroenterology, 125, 1011, 10.1016/j.gastro.2003.08.001
Assiri, 2013, Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study, Lancet Infect Dis, 13, 752, 10.1016/S1473-3099(13)70204-4
Cho, 2016, MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study, Lancet, 388, 994, 10.1016/S0140-6736(16)30623-7
Garbati, 2016, A Comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes, PLoS One, 11, 10.1371/journal.pone.0165978
Pan, 2020, Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study, Am J Gastroenterol., 115, 766, 10.14309/ajg.0000000000000620
Xiao, 2020, Infectious SARS-CoV-2 in feces of patient with severe COVID-19, Emerg Infect Dis, 26, 1920, 10.3201/eid2608.200681
Han, 2020, Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes, Am J Gastroenterol, 115, 916, 10.14309/ajg.0000000000000664
D'Amico, 2020, Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management, Clin Gastroenterol Hepatol, 18, 1663, 10.1016/j.cgh.2020.04.001
Golonka, 2020, Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease, Physiol Genomics, 52, 217, 10.1152/physiolgenomics.00033.2020
Xie, 2020, Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests, Int J Infect Dis, 93, 264, 10.1016/j.ijid.2020.02.050
Xu, 2005, Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase, Eur J Clin Microbiol Infect Dis, 24, 165, 10.1007/s10096-005-1299-5
Han, 2020, Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul. Emerg Infect Dis., 26
Kim, 2020, Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean Cohort Study on COVID-19, J Korean Med Sci, 35, e142, 10.3346/jkms.2020.35.e142
Zou, 2020, SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients, N Engl J Med, 382, 1177, 10.1056/NEJMc2001737
Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis. medRxiv. preprint.
Sun, 2020, Cytokine storm intervention in the early stages of COVID-19 pneumonia, Cytokine Growth Factor Rev, 53, 38, 10.1016/j.cytogfr.2020.04.002
Wilcox, 2020, The efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection: current understanding and gap analysis, Open Forum Infect Dis, 7, 10.1093/ofid/ofaa114
Mazza, 2020, A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis, Gut, 69, 1148, 10.1136/gutjnl-2020-321183
Meini, 2020, Pneumatosis intestinalis in COVID-19, BMJ Open Gastroenterol, 7, 10.1136/bmjgast-2020-000434
Xu, 2020, [Management of COVID-19: the Zhejiang experience], Zhejiang Da Xue Xue Bao Yi Xue Ban, 49, 147
Xu, 2020, [Management of corona virus disease-19 (COVID-19): the Zhejiang experience], Zhejiang Da Xue Xue Bao Yi Xue Ban, 49, 0
Wong, 2020, Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis, J Infect, 81, e31, 10.1016/j.jinf.2020.06.012
Ianiro, 2020, Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel, Lancet Gastroenterol Hepatol, 5, 430, 10.1016/S2468-1253(20)30082-0
Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052
Mirabito Colafella, 2019, The renin-angiotensin-aldosterone system and its therapeutic targets, Exp Eye Res, 186, 10.1016/j.exer.2019.05.020
Mendoza-Torres, 2015, ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension, Ther Adv Cardiovasc Dis, 9, 217, 10.1177/1753944715597623
Calo, 2010, ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications, J Nephrol, 23, 472
Kuba, 2006, Angiotensin-converting enzyme 2 in lung diseases, Curr Opin Pharmacol, 6, 271, 10.1016/j.coph.2006.03.001
Fandriks, 2010, The angiotensin II type 2 receptor and the gastrointestinal tract, J Renin Angiotensin Aldosterone Syst, 11, 43, 10.1177/1470320309347788
Fandriks, 2011, The renin-angiotensin system and the gastrointestinal mucosa, Acta Physiol (Oxf), 201, 157, 10.1111/j.1748-1716.2010.02165.x
Feng, 2020, The Interplay of renin-angiotensin system and toll-like receptor 4 in the inflammation of diabetic nephropathy, J Immunol Res, 2020, 10.1155/2020/6193407
Garg, 2012, Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract, Aliment Pharmacol Ther, 35, 414, 10.1111/j.1365-2036.2011.04971.x
Hikmet, 2020, The protein expression profile of ACE2 in human tissues, Mol Syst Biol, 16, e9610, 10.15252/msb.20209610
Lee, 2020, Relative abundance of SARS-CoV-2 entry genes in the enterocytes of the lower gastrointestinal tract, Genes (Basel), 11, 645, 10.3390/genes11060645
Cole-Jeffrey, 2015, ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy, J Cardiovasc Pharmacol, 66, 540, 10.1097/FJC.0000000000000307
Hashimoto, 2012, ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation, Nature, 487, 477, 10.1038/nature11228
Chen, 2020, The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2, Cardiovasc Res, 116, 1097, 10.1093/cvr/cvaa078
Yang, 2020, Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 infectivity, Hypertension, 76, e1, 10.1161/HYPERTENSIONAHA.120.15360
Villapol, 2015, Neuroprotective effects of angiotensin receptor blockers, Am J Hypertens, 28, 289, 10.1093/ajh/hpu197
Tikellis, 2012, Angiotensin-Converting Enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease, Int J Pept, 2012, 10.1155/2012/256294
Tikellis, 2014, Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes, Am J Physiol Renal Physiol, 306, F773, 10.1152/ajprenal.00264.2013
Tikellis, 2011, Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease, Curr Opin Nephrol Hypertens, 20, 62, 10.1097/MNH.0b013e328341164a
Garg, 2020, Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?, Gut., 69, 841, 10.1136/gutjnl-2019-318512
Magrone, 2020, Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target - a perspective, Endocr Metab Immune Disord Drug Targets, 20, 807, 10.2174/1871530320666200427112902
Dijkman, 2012, Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63, J Gen Virol, 93, 1924, 10.1099/vir.0.043919-0
Saavedra, 2020, Angiotensin receptor blockers and COVID-19, Pharmacol Res, 156, 10.1016/j.phrs.2020.104832
Perlot, 2013, ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition, Microbes Infect, 15, 866, 10.1016/j.micinf.2013.08.003
Gou W, 2020, Gut microbiota may underlie the predisposition of healthy individuals to COVID-19, medRxiv.
Zuo, 2020, Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge, Gastroenterology, 26
Guo, 2020, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status, Mil Med Res, 7, 11
Zuo, 2020, Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19, Gut, 20
Gu, 2020, Alterations of the gut microbiota in patients with COVID-19 or H1N1 Influenza, Clin Infect Dis, 4
Zhang, 2020, Metatranscriptomic characterization of COVID-19 identified a host transcriptional classifier associated with immune signaling, Clin Infect Dis, 28
Esteve, 2020, National age and coresidence patterns shape COVID-19 vulnerability, Proc Natl Acad Sci U S A, 117, 16118, 10.1073/pnas.2008764117
Darbani, 2020, The expression and polymorphism of entry machinery for COVID-19 in human: juxtaposing population groups, gender, and different tissues, Int J Environ Res Public Health, 17, 3433, 10.3390/ijerph17103433
Fuchs, 2018, Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions, Future Microbiol, 13, 1537, 10.2217/fmb-2018-0157
Romano-Keeler, 2014, Early life establishment of site-specific microbial communities in the gut, Gut Microbes, 5, 192, 10.4161/gmic.28442
Yatsunenko, 2012, Human gut microbiome viewed across age and geography, Nature, 486, 222, 10.1038/nature11053
Claesson, 2011, Composition, variability, and temporal stability of the intestinal microbiota of the elderly, Proc Natl Acad Sci U S A, 108, 4586, 10.1073/pnas.1000097107
Wiley, 2017, The microbiota-gut-brain axis as a key regulator of neural function and the stress response: Implications for human and animal health, J Anim Sci, 95, 3225
Mariat, 2009, The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age, BMC Microbiol, 9, 123, 10.1186/1471-2180-9-123
Zwielehner, 2009, Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly, Exp Gerontol, 44, 440, 10.1016/j.exger.2009.04.002
Makivuokko, 2010, The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition, Br J Nutr, 103, 227, 10.1017/S0007114509991553
Hopkins, 2002, Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection, J Med Microbiol, 51, 448, 10.1099/0022-1317-51-5-448
Woodmansey, 2004, Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects, Appl Environ Microbiol, 70, 6113, 10.1128/AEM.70.10.6113-6122.2004
Porcheddu, 2020, Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China, J Infect Dev Ctries, 14, 125, 10.3855/jidc.12600
Shikany, 2019, Association of dietary patterns with the gut microbiota in older, community-dwelling men, Am J Clin Nutr, 110, 1003, 10.1093/ajcn/nqz174
Sanmiguel, 2015, Gut microbiome and obesity: a plausible explanation for obesity, Curr Obes Rep, 4, 250, 10.1007/s13679-015-0152-0
Briand-Mesange, 2020
Michalakis, 2020, SARS-CoV-2 infection and obesity: common inflammatory and metabolic aspects, Diabetes Metab Syndr, 14, 469, 10.1016/j.dsx.2020.04.033
Gupta, 2020, Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc), Diabetes Metab Syndr, 14, 251, 10.1016/j.dsx.2020.03.012
Nogueira-de-Almeida, 2020, COVID-19 and obesity in childhood and adolescence: A clinical review, J Pediatr (Rio J), 10.1016/j.jped.2020.07.001
de Lucena, 2020, Mechanism of inflammatory response in associated comorbidities in COVID-19, Diabetes Metab Syndr, 14, 597, 10.1016/j.dsx.2020.05.025
Malavazos, 2020, Targeting the Adipose Tissue in COVID-19, Obesity (Silver Spring), 28, 1178, 10.1002/oby.22844
Ryan, 2020, Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in Coronavirus disease 2019?, Obesity (Silver Spring), 28, 1191, 10.1002/oby.22843
Mancuso, 2016, The role of adipokines in chronic inflammation, Immunotargets Ther, 5, 47, 10.2147/ITT.S73223
Fung, 2017, Interactions between the microbiota, immune and nervous systems in health and disease, Nat Neurosci, 20, 145, 10.1038/nn.4476
Lei, 2020, A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China. Travel Med Infect Dis., 10.1016/j.tmaid.2020.101664
Rogers, 2020, Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic, Lancet Psychiatry, 7, 611, 10.1016/S2215-0366(20)30203-0
Serrano-Castro, 2020, Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?, Neurologia., 35, 245, 10.1016/j.nrl.2020.04.002
Heintz-Buschart, 2016, Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes, Nat Microbiol, 2, 16180, 10.1038/nmicrobiol.2016.180
Teuwen, 2020, COVID-19: the vasculature unleashed, Nat Rev Immunol, 20, 389, 10.1038/s41577-020-0343-0
Anselmi, 2020, Gut microbiota and cardiovascular diseases: a critical review, Cardiol Rev
Jayachandran, 2019, A critical review on diet-induced microbiota changes and cardiovascular diseases, Crit Rev Food Sci Nutr, 1
Novakovic, 2020, Role of gut microbiota in cardiovascular diseases, World J Cardiol, 12, 110, 10.4330/wjc.v12.i4.110
Louca, 2020, Genomic determinants of hypertension with a focus on metabolomics and the gut microbiome, Am J Hypertens, 33, 473, 10.1093/ajh/hpaa022
Chen, 2020, Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives: a randomized, double-blind, placebo-controlled trial, Hypertension., 76, 73, 10.1161/HYPERTENSIONAHA.120.14800
Ashuro, 2020, Review on the alteration of gut microbiota: the role of HIV Infection and old age, AIDS Res Hum Retroviruses, 36, 556, 10.1089/aid.2019.0282
Illiano, 2020, The mutual interplay of gut microbiota, diet and human disease, FEBS J, 287, 833, 10.1111/febs.15217
Sirisinha, 2016, The potential impact of gut microbiota on your health: current status and future challenges, Asian Pac J Allergy Immunol, 34, 249
Zuo, 2020, Alterations in gut microbiota of patients with COVID-19 during time of hospitalization, Gastroenterology, 20
Elmadfa, 2019, The Role of the Status of Selected Micronutrients in Shaping the Immune Function, Endocr Metab Immune Disord Drug Targets, 19, 1100, 10.2174/1871530319666190529101816
Schofield, 1997, Severe malnutrition in children: high case-fatality rates can be reduced, Afr Health, 19, 17
Giorgi, 1984, [Zinc and chronic enteropathies], Pediatr Med Chir, 6, 625
Allison, 2019, Changes in nutrient intake and inflammation following an anti-inflammatory diet in spinal cord injury, J Spinal Cord Med, 42, 768, 10.1080/10790268.2018.1519996
McAfee, 2010, Red meat consumption: an overview of the risks and benefits, Meat Sci, 84, 1, 10.1016/j.meatsci.2009.08.029
Keysser, 2001, [Are there effective dietary recommendations for patients with rheumatoid arthritis?], Z Rheumatol, 60, 17
Zabetakis, 2020, COVID-19: the inflammation link and the role of nutrition in potential mitigation, Nutrients, 12, 1466, 10.3390/nu12051466
San, 2018, Chronic low grade inflammation measured by dietary inflammatory index and its association with obesity among school teachers in Yangon, Myanmar, Asia Pac J Clin Nutr, 27, 92
Owczarek, 2016, Diet and nutritional factors in inflammatory bowel diseases, World J Gastroenterol, 22, 895, 10.3748/wjg.v22.i3.895
Santillo, 2006, Role of vitamins, minerals and supplements in the prevention and management of prostate cancer, Int Braz J Urol, 32, 3, 10.1590/S1677-55382006000100002
Tucker, 2003, Nutritional enhancement of plants, Curr Opin Biotechnol, 14, 221, 10.1016/S0958-1669(03)00031-4
White-O'Connor, 1986, Nutrient intake and obesity in a multidisciplinary assessment of osteoarthritis, Clin Ther, 9, 30
Quesada-Gomez, 2020, Vitamin D Receptor stimulation to reduce Acute Respiratory Distress Syndrome (ARDS) in patients with Coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166, J Steroid Biochem Mol Biol, 10.1016/j.jsbmb.2020.105719
Ribeiro, 2020, Does Vitamin D play a role in the management of Covid-19 in Brazil?, Rev Saude Publica, 54, 53, 10.11606/s1518-8787.2020054002545
Aygun, 2020, Vitamin D can prevent COVID-19 infection-induced multiple organ damage, Naunyn Schmiedebergs Arch Pharmacol, 393, 1157, 10.1007/s00210-020-01911-4
Mitchell, 2020, Vitamin-D and COVID-19: do deficient risk a poorer outcome?, Lancet Diabetes Endocrinol, 8, 570, 10.1016/S2213-8587(20)30183-2
Hastie, 2020, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr, 14, 561, 10.1016/j.dsx.2020.04.050
Hemila, 2020, Vitamin C as a possible therapy for COVID-19, Infect Chemother, 52, 222, 10.3947/ic.2020.52.2.222
Molloy, 2020, Vitamin D, Covid-19 and Children, Ir Med J., 113, 64
Baud, 2020, Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic, Front Public Health, 8, 186, 10.3389/fpubh.2020.00186
Lombardi, 2018, Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease, J Nutr Biochem, 61, 1, 10.1016/j.jnutbio.2018.04.004
Mohajeri, 2018, The role of the microbiome for human health: from basic science to clinical applications, Eur J Nutr, 57, 1, 10.1007/s00394-018-1703-4
Patterson, 2014, Gut microbiota, the pharmabiotics they produce and host health, Proc Nutr Soc, 73, 477, 10.1017/S0029665114001426
Trompette, 2018, Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism, Immunity, 48, 992, 10.1016/j.immuni.2018.04.022
Hills, 2019, Gut microbiome: profound implications for diet and disease, Nutrients, 11, 1613, 10.3390/nu11071613
Conte, 2020, Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection, Ther Adv Respir Dis, 14, 10.1177/1753466620937170